CSL (@CSL) / X

CSL

1,547 posts

CSL

@CSL

Since our start in 1916, we have been driven by our promise to identify, develop and deliver innovations so our patients can live life to the fullest.

Melbourne, Victoria

Joined October 2015

CSL
@CSL
Mar 9
Today, we broke ground on a $1.5 billion investment to expand our plasma manufacturing capacity in Kankakee, Illinois. Read how this will support the production of plasma-derived therapies and create new jobs in the US: newsroom.csl.com/2026-03-09-CSL… #CSL #PlasmaDerivedTherapies
1.5K
CSL
@CSL
Feb 10
Today we announced our half‑year results. Read the full ASX announcement for details: bit.ly/4tzf89M #CSL
1.3K
CSL
@CSL
Feb 10
Today we’ve announced that Gordon Naylor has been appointed interim Chief Executive Officer and Managing Director, following Dr Paul McKenzie’s decision to retire. Read more: bit.ly/46DKj9K
1.7K
CSL
@CSL
Nov 18, 2025
Today, we announced an upcoming $1.5b in future U.S. capital investments, further strengthening our contribution to the U.S. healthcare ecosystem. This expansion builds on our significant U.S. presence and over $3b invested since 2018. This investment will generate hundreds of
1.1K
CSL
@CSL
Oct 6, 2025
October is #PlasmaAwarenessMonth, an opportunity to thank our plasma donors for their generosity and to bring awareness of the important role that plasma plays in helping patients. Our plasma-derived therapies are made possible by the donation of plasma, and these therapies
1.3K
CSL
@CSL
Aug 18, 2025
Today we shared our full-year results for FY25. Take a look at some of the key financial and operational highlights. For more details visit our Investor Centre: investors.csl.com #CSL #FullYearResults
00:00
1.6K
CSL
@CSL
Aug 8, 2025
The first and only once-monthly treatment targeting factor XIIa to prevent recurrent attacks of #HAE has been authorized by Health Canada, offering those living with HAE a convenient administration approach. Read more: bit.ly/46MYCtN
1K
CSL
@CSL
Jun 23, 2025
Applications for the 2026 CSL Centenary Fellowships will close on 30 June. We are inviting Australia’s top early-mid career scientists to apply for next year’s fellowships now. bit.ly/466kBez
1.8K
CSL
@CSL
Jun 18, 2025
Innovation meets convenience with our first homegrown mAb to gain approval, offering a new option that may help patients manage their condition. We’re proud to bring this innovation to the HAE community. bit.ly/4jZZuOH
1K
CSL reposted
Elizabeth Day 🇦🇺
@AusAmbCH
Jun 13, 2025
@CSL Behring exemplifies the enduring #partnership between Australia and Switzerland, merging Australian #innovation with Swiss precision. It was a pleasure to attend the 25th Anniversary of CSL Behring celebrations in Bern yesterday. @CSLVifor
754
CSL
@CSL
Jun 17, 2025
The U.S. FDA has approved the only once-monthly treatment targeting factor XIIa to prevent attacks of HAE. This reflects our commitment to HAE patients around the world, a community we have proudly supported for over four decades. Read more: bit.ly/3FFkoEI.
608
CSL
@CSL
Jun 9, 2025
Dr @qizhang85 from @SAiGENCI, @UniofAdelaide is doing important #research with the support of a #CSLCentenaryFellowship. Applications for 2026 are now open: bit.ly/3FxGI2Z
00:00
593
CSL
@CSL
May 26, 2025
.@DrClareWeeden from @WEHI_research is doing important #research with the support of a #CSLCentenaryFellowship. Applications for 2026 are now open: bit.ly/3SmhVS7 #CSL
00:00
896